Evidence method
Level · gp.fundamentals.capex_revenue_ratio
78.23% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ABCL · Jun 30, 2025
AbCellera Biologics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001703057-25-000011General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-189.67% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
133.29% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-290.24% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
229.53% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
83.17% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History18 statesSelf-history eligible
Mar 31, 20220/6 normalizedLevel 3Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20235/6 normalizedLevel 3Sep 30, 20235/6 normalizedLevel 3Dec 31, 20235/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 251.15%
- Current
- 78.23%
- Delta
- -172.91%
- Previous
- -272.82%
- Current
- -189.67%
- Delta
- 83.15%
- Previous
- -57.45%
- Current
- 133.29%
- Delta
- 190.75%
- Previous
- -1479.57%
- Current
- -290.24%
- Delta
- 1189.33%
- Previous
- 1003.45%
- Current
- 229.53%
- Delta
- -773.92%
- Previous
- 349.14%
- Current
- 83.17%
- Delta
- -265.97%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ABCL Fundamental State →Transitioned To · ABCL Fundamental State →Transitioned To · ABCL CAPEX_INTENSITY_DECREASED →Transitioned To · ABCL CASH_GENERATION_INCREASED →Transitioned To · ABCL GROWTH_INCREASED →Transitioned To · ABCL PROFITABILITY_INCREASED →Transitioned To · ABCL R_AND_D_INTENSITY_DECREASED →Transitioned To · ABCL SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.